Disorder Of Skin — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for disorder of skin. 19 active patents protecting 2 drugs from 1+ originators. First major cliff: 2027. Daily refresh.

2
Approved drugs
19
Active US patents
61/100
Avg vulnerability
—
Annual revenue covered

Originators in Disorder Of Skin

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Schering) 19 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating disorder of skin. Each bar = one year. Y-axis scaled to peak year (5 patents).

5
27
2
28
2
30
1
32
3
34
1
36
3
37
1
39
1
41

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Decadron
dexamethasone
 Generic (originally Merck) 15 46 — 2027-12-19
Deltasone
prednisone
 Generic (originally Schering) 4 76 — 2027-08-03

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8168218 Deltasone method of use 80 2028-01-07
9504699 Deltasone method of use 75 2027-08-03
9504699 Deltasone method of use 75 2027-08-03
9504699 Deltasone method of use 75 2027-08-03
8101582 Decadron method of use 63 2027-12-19
7795316 Decadron method of use 63 2028-08-03
12150896 Decadron method of use 58 2036-10-07
12144889 Decadron method of use 58 2041-04-26
11458041 Decadron method of use 53 2037-11-16
11304961 Decadron method of use 53 2037-12-18

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10537585 Decadron formulation 25 2037-12-18
10159683 Decadron formulation 25 2034-05-23
10799642 Decadron formulation 31 2032-05-11
8409606 Decadron formulation 31 2030-05-14
8450287 Decadron formulation 38 2027-12-19
10022502 Decadron method of use 45 2034-06-22
10028965 Decadron method of use 45 2034-05-23
8563027 Decadron method of use 51 2030-02-12
11097061 Decadron method of use 53 2039-06-23
11304961 Decadron method of use 53 2037-12-18

Related